This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leibovici, L.
Right arrow Articles by Pitlik, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leibovici, L.
Right arrow Articles by Pitlik, S. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 05 1997, 1127-1133, Vol 41, No. 5
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study

L Leibovici, M Paul, O Poznanski, M Drucker, Z Samra, H Konigsberger and SD Pitlik
Department of Medicine, Rabin Medical Center, Beilinson Campus, Petah- Tiqva, Israel. leibovic@post.tau.ac.il

The aim of the present study was to test whether the combination of a beta-lactam drug plus an aminoglycoside has advantage over monotherapy for severe gram-negative infections. Of 2,124 patients with gram- negative bacteremia surveyed prospectively, 670 were given inappropriate empirical antibiotic treatment and the mortality rate in this group was 34%, whereas the mortality rate was 18% for 1,454 patients given appropriate empirical antibiotic treatment (P = 0.0001). The mortality rates for patients given appropriate empirical antibiotic treatment were 17% for 789 patients given a single beta-lactam drug, 19% for 327 patients given combination treatment, 24% for 249 patients given a single aminoglycoside, and 29% for 89 patients given other antibiotics (P = 0.0001). When patients were stratified according to risk factors for mortality other than antibiotic treatment, combination therapy showed no advantage over treatment with a single beta-lactam drug except for neutropenic patients (odds ratio [OR] for mortality, 0.5; 95% confidence interval [95% CI], 0.2 to 1.3) and patients with Pseudomonas aeruginosa bacteremia (OR, 0.7; 95% CI, 0.3 to 1.8). On multivariable logistic regression analysis including all risk factors for mortality, combination therapy had no advantage over therapy with a single beta-lactam drug. The mortality rate for patients treated with a single appropriate aminoglycoside was higher than that for patients given a beta-lactam drug in all strata except for patients with urinary tract infections. When the results of blood cultures were known, 1,878 patients were available for follow-up. Of these, 816 patients were given a single beta-lactam drug, 442 were given combination treatment, and 193 were given a single aminoglycoside. The mortality rates were 13, 15, and 23%, respectively (P = 0.0001). Both on stratified and on multivariable logistic regression analyses, combination treatment showed a benefit over treatment with a single beta-lactam drug only for neutropenic patients (OR, 0.2; 95% CI, 0.05 to 0.7). In summary, combination treatment showed no advantage over treatment with an appropriate beta-lactam drug in nonneutropenic patients with gram- negative bacteremia.


This article has been cited by other articles:

  • Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J. E., Dodek, P., Wood, G., Kumar, A., Simon, D., Peters, C., Ahsan, M., Chateau, D., the Cooperative Antimicrobial Therapy of Septic Sh, (2009). Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock. Chest 136: 1237-1248 [Abstract] [Full Text]  
  • Al-Hasan, M. N., Wilson, J. W., Lahr, B. D., Thomsen, K. M., Eckel-Passow, J. E., Vetter, E. A., Tleyjeh, I. M., Baddour, L. M. (2009). {beta}-Lactam and Fluoroquinolone Combination Antibiotic Therapy for Bacteremia Caused by Gram-Negative Bacilli. Antimicrob. Agents Chemother. 53: 1386-1394 [Abstract] [Full Text]  
  • Leibovici, L., Vidal, L., Paul, M. (2009). Aminoglycoside drugs in clinical practice: an evidence-based approach. J Antimicrob Chemother 63: 246-251 [Abstract] [Full Text]  
  • Vidal, L., Gafter-Gvili, A., Borok, S., Fraser, A., Leibovici, L., Paul, M. (2007). Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 60: 247-257 [Abstract] [Full Text]  
  • Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-d., Choe, K.-W. (2005). Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome. Antimicrob. Agents Chemother. 49: 760-766 [Abstract] [Full Text]  
  • Enoch, D. A, Simpson, A. J., Kibbler, C. C (2004). Predictive value of isolating Pseudomonas aeruginosa from aerobic and anaerobic blood culture bottles. J Med Microbiol 53: 1151-1154 [Abstract] [Full Text]  
  • Kim, S.-H., Park, W.-B., Lee, K.-D., Kang, C.-I., Bang, J.-W., Kim, H.-B., Kim, E.-C., Oh, M.-d., Choe, K.-W. (2004). Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 54: 489-497 [Abstract] [Full Text]  
  • Paul, M., Benuri-Silbiger, I., Soares-Weiser, K., Leibovici, L. (2004). {beta} lactam monotherapy versus {beta} lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328: 668- [Abstract] [Full Text]  
  • Klibanov, O. M, Raasch, R. H, Rublein, J. C (2004). Single Versus Combined Antibiotic Therapy for Gram-Negative Infections. The Annals of Pharmacotherapy 38: 332-337 [Abstract] [Full Text]  
  • Chamot, E., Boffi El Amari, E., Rohner, P., Van Delden, C. (2003). Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia. Antimicrob. Agents Chemother. 47: 2756-2764 [Abstract] [Full Text]  
  • Paul, M., Soares-Weiser, K., Leibovici, L. (2003). {beta} lactam monotherapy versus {beta} lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 326: 1111- [Abstract] [Full Text]  
  • Fowler, R. A., Flavin, K. E., Barr, J., Weinacker, A. B., Parsonnet, J., Gould, M. K. (2003). Variability in Antibiotic Prescribing Patterns and Outcomes in Patients With Clinically Suspected Ventilator-Associated Pneumonia. Chest 123: 835-844 [Abstract] [Full Text]  
  • Chastre, J., Fagon, J.-Y. (2002). Ventilator-associated Pneumonia. Am. J. Respir. Crit. Care Med. 165: 867-903 [Abstract] [Full Text]  
  • Ambrose, P. G., Owens, R. C. Jr, Garvey, M. J., Jones, R. N. (2002). Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime. J Antimicrob Chemother 49: 445-453 [Abstract] [Full Text]  
  • Rello, J., Paiva, J. A., Baraibar, J., Barcenilla, F., Bodi, M., Castander, D., Correa, H., Diaz, E., Garnacho, J., Llorio, M., Rios, M., Rodriguez, A., Sole-Violan, J. (2001). International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia. Chest 120: 955-970 [Abstract] [Full Text]  
  • Kollef, M. H., Fraser, V. J. (2001). Antibiotic Resistance in the Intensive Care Unit. ANN INTERN MED 134: 298-314 [Abstract] [Full Text]  
  • Chang, T. C., Huang, A. H. (2000). Rapid Differentiation of Fermentative from Nonfermentative Gram-Negative Bacilli in Positive Blood Cultures by an Impedance Method. J. Clin. Microbiol. 38: 3589-3594 [Abstract] [Full Text]  
  • Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., Kollef, M. H. (2000). The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting. Chest 118: 146-155 [Abstract] [Full Text]  
  • Crabtree, T. D., Pelletier, S. J., Gleason, T. G., Pruett, T. L., Sawyer, R. G. (1999). Analysis of Aminoglycosides in the Treatment of Gram-negative Infections in Surgical Patients. Arch Surg 134: 1293-1299 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»